Cidara Therapeutics/ US1717572069 /
| 2024-05-24 9:54:44 PM | Chg. +0.23 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 12.17USD | +1.93% | 630 Turnover: 7,591.40 |
-Bid Size: - | -Ask Size: - | 12.17 | 11.78 |
GlobeNewswire
05-15
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-14
CDTX INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors ...
GlobeNewswire
05-11
CDTX INVESTOR ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cidara Therapeutics, Inc. Investors t...
GlobeNewswire
04-26
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388...
GlobeNewswire
04-26
CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on...
GlobeNewswire
04-24
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Priva...
GlobeNewswire
04-24
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Cl...
GlobeNewswire
04-22
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financia...
GlobeNewswire
04-05
Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the America...
GlobeNewswire
03-06
Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at Ame...
GlobeNewswire
02-12
Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO
GlobeNewswire
01-29
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidia...
GlobeNewswire
2023-12-22
Cidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasi...
GlobeNewswire
2023-12-07
Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates a...
GlobeNewswire
2023-12-06
Cidara Therapeutics Announces Completion of Enrollment in Phase 3 Restore Trial of Rezafungin in Chi...
GlobeNewswire
2023-11-30
Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO ...
GlobeNewswire
2023-11-03
Cidara Therapeutics Presents Preclinical Data on Novel Drug-Fc Conjugate CBO421 at SITC’s 38ᵗʰ Annua...
GlobeNewswire
2023-11-02
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire
2023-10-13
Cidara Therapeutics and Mundipharma receive positive CHMP opinion for rezafungin for the treatment o...
GlobeNewswire
2023-10-11
Cidara Therapeutics Presents New Preclinical and Clinical Data on Novel Drug-Fc Conjugate CD388 at I...
GlobeNewswire
2023-09-29
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
